Neutralization of Newcastle disease virus by monoclonal antibodies to the hemagglutinin-neuraminidase glycoprotein: requirement for antibodies to four sites for complete neutralization
- PMID: 6205169
- PMCID: PMC254458
- DOI: 10.1128/JVI.51.2.445-451.1984
Neutralization of Newcastle disease virus by monoclonal antibodies to the hemagglutinin-neuraminidase glycoprotein: requirement for antibodies to four sites for complete neutralization
Abstract
The neutralizing characteristics of monoclonal antibodies directed to four antigenic sites on the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus were determined. Neutralization by each antibody resulted in a persistent fraction of nonneutralized virus which varied from 1 to 17% depending on the hemagglutinin-neuraminidase site recognized, but not on the antibody. The addition of antibodies to all four sites on the hemagglutinin-neuraminidase glycoprotein was required to give a level of neutralization comparable with that obtained with polyclonal mouse antiserum. The high persistent fractions were not due to viral aggregates, a high level of variants in the virus stock, the use of insufficient antibody, low antibody avidity, or an effect peculiar to the use of the chicken cells as host. The addition of rabbit anti-mouse immunoglobulin to the persistent fraction left by any of the antibodies resulted in a further reduction in infectivity, often by as much as two logs. Thus, some viral particles are capable of binding antibody while retaining their infectivity. The implications of these findings to the mechanism of neutralization are discussed.
Similar articles
-
Selection of unique antigenic variants of Newcastle disease virus with neutralizing monoclonal antibodies and anti-immunoglobulin.Proc Natl Acad Sci U S A. 1985 Oct;82(20):7106-10. doi: 10.1073/pnas.82.20.7106. Proc Natl Acad Sci U S A. 1985. PMID: 2413460 Free PMC article.
-
Functional and neutralization profile of seven overlapping antigenic sites on the HN glycoprotein of Newcastle disease virus: monoclonal antibodies to some sites prevent viral attachment.Virus Res. 1989 Jul;13(3):245-61. doi: 10.1016/0168-1702(89)90019-1. Virus Res. 1989. PMID: 2475989
-
Monoclonal antibodies as functional probes of the HN glycoprotein of Newcastle disease virus: antigenic separation of the hemagglutinating and neuraminidase sites.J Immunol. 1984 Oct;133(4):2215-9. J Immunol. 1984. PMID: 6470488
-
Monoclonal antibodies identify a strain-specific epitope on the HN glycoprotein of Newcastle disease virus strain Australia-Victoria.Virus Res. 1984 Oct;1(7):513-25. doi: 10.1016/0168-1702(84)90009-1. Virus Res. 1984. PMID: 6085438
-
Immunochemistry of variants of influenza virus hemagglutinin and neuraminidase.Adv Exp Med Biol. 1985;185:149-74. doi: 10.1007/978-1-4684-7974-4_10. Adv Exp Med Biol. 1985. PMID: 3907308 Review.
Cited by
-
References.Perspect Med Virol. 1986;2:209-245. doi: 10.1016/S0168-7069(08)70043-0. Epub 2008 May 29. Perspect Med Virol. 1986. PMID: 32287595 Free PMC article. Review. No abstract available.
-
Neutralization map of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus: domains recognized by monoclonal antibodies that prevent receptor recognition.J Virol. 1991 Sep;65(9):4999-5006. doi: 10.1128/JVI.65.9.4999-5006.1991. J Virol. 1991. PMID: 1651419 Free PMC article.
-
Virus-neutralizing monoclonal antibody to a conserved epitope on the duck hepatitis B virus pre-S protein.J Virol. 1990 Mar;64(3):1290-7. doi: 10.1128/JVI.64.3.1290-1297.1990. J Virol. 1990. PMID: 1689393 Free PMC article.
-
The synergistic neutralization of Newcastle disease virus by two monoclonal antibodies to its haemagglutinin-neuraminidase protein.Arch Virol. 1986;90(1-2):135-44. doi: 10.1007/BF01314151. Arch Virol. 1986. PMID: 3729723
-
Topological and operational delineation of antigenic sites on the HN glycoprotein of Newcastle disease virus and their structural requirements.J Virol. 1986 Dec;60(3):987-93. doi: 10.1128/JVI.60.3.987-993.1986. J Virol. 1986. PMID: 2431164 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources